Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.

Abstract : : 1-acetyl,2-docosahexaenoyl-glycerophosphocholine (AceDoPC) has been made to prevent docosahexaenoyl (DHA) to move to the sn-1 position as it rapidly does when present in 1-lyso,2-docosahexaenoyl-GPC (lysoPC-DHA), an efficient DHA transporter to the brain. When incubated with human blood, AceDoPC behaves closer to lysoPC-DHA than PC-DHA in terms of binding to plasma albumin and lipoproteins, and DHA incorporation into platelets and red cells. In addition, AceDoPC prevents more efficiently the deleterious effects of the experimental stroke in rats than does unesterified DHA. Also, AceDoPC inhibits platelet-activating factor-induced human blood platelet aggregation. Overall, AceDoPC might act as an efficient DHA transporter to the brain, and as a neuro-protective agent by itself.
Type de document :
Article dans une revue
Prostaglandins, Leukotrienes and Essential Fatty Acids, Elsevier, 2014, 92, pp.63-65. 〈10.1016/j.plefa.2014.01.005〉
Liste complète des métadonnées

Littérature citée [18 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00958127
Contributeur : Evelyne Vericel <>
Soumis le : mardi 11 mars 2014 - 16:51:32
Dernière modification le : mardi 24 avril 2018 - 12:10:01
Document(s) archivé(s) le : mercredi 11 juin 2014 - 13:11:04

Fichier

Lagarde_et_al._PLEFA_2013-2014...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Michel Lagarde, Mayssa Hachem, Nathalie Bernoud-Hubac, Martine Picq, Evelyne Véricel, et al.. Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.. Prostaglandins, Leukotrienes and Essential Fatty Acids, Elsevier, 2014, 92, pp.63-65. 〈10.1016/j.plefa.2014.01.005〉. 〈inserm-00958127〉

Partager

Métriques

Consultations de la notice

830

Téléchargements de fichiers

542